Made to Measure

Often attributed to management guru Peter Drucker but perhaps coined first by 19th century scientist William Thompson, Lord Kelvin, there is more to this famous quotation than first meets the eye.On the one hand, it is common sense – you do, you measure, you improve. But, on the other hand, can your activity be measured? Do the tools and metrics even exist? And, are you measuring the right things? Measuring can be a tricky business.Patient-centricity has transformed pharma, yet few companies effectively measure the impact of their patient engagement activities let alone track the shift in their people towards a patients-first mindset.So, how can we improve unless we measure? Where does this vacuum leave the patient-centric champions scattered across pharma? Does the next iteration of patient-centricity need metrics, or can the industry move forward without them?In the most recent annual benchmarking survey carried out by the Aurora Project, 42% of respondents said their company measured their patient-centric efforts.“I expected that number to be far lower,” says author, speaker and Aurora Project founder, Jill Donahue, who is “on a mission to lift pharma”. In her conversations with executives right across the industry, the consensus is that no one had yet worked out all the kinks.“People tell me that measurement of patient-centricity is the Holy Grail. So, I’m left wondering what the 42% are measuring. Is it enterprise-wide or small-scale?”Janssen is perhaps t...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news